The strength of our work is the homogeneity of our study group (autoimmune etiology of the disease, treatment with hydrocortisone) and the use of novel methods (first report of TBS and sclerostin in Addison`s disease). This evidence concerns the gene SOST and primary adrenal insufficiency.